
NRXS · AMEX
NeurAxis, Inc.
$7.42 -0.05 (-0.67%)
Company overview
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended for use in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company primarily serves hospitals and clinics. NeurAxis, Inc. was formerly known as Innovative Health Solutions, Inc. and changed its name in March 2022. Founded in 2011, the company is headquartered in Carmel, Indiana.
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- AMEX
- Market cap
- $93.2M
- Employees
- 21
- Headquarters
- Carmel, IN
- Website
- neuraxis.com
- CEO
- Brian Carrico
- Listed
- August 9, 2023
- P/E
- -9.28
- Dividend yield
- 0.00%
Company financials
- Revenue
- $4.3M
- Gross profit
- $3.6M
- Operating income
- -$7.3M
- EBITDA
- -$7.1M
- Net income
- -$7.3M
- EPS
- -$0.80
- Total assets
- $8.7M
- Total debt
- $169,524
- Gross margin
- 85.01%
- Net margin
- -170.11%
- Earnings yield
- -10.78%
Showing FY 2025